SKIN TREAT

Novel approaches for the development of customized skin treatments and services (Test case: Dead Sea Minerals and Conventional drugs)

 Coordinatore AHAVA DEAD SEA LABORATORIES LTD 

 Organization address address: Hatsoref street 5
city: HOLON
postcode: 58856

contact info
Titolo: Mr.
Nome: Ofer
Cognome: Achdut
Email: send email
Telefono: +972 3 557 1119
Fax: +972 3 5581424

 Nazionalità Coordinatore Israel [IL]
 Sito del progetto http://www.skintreat.eu
 Totale costo 5˙446˙376 €
 EC contributo 3˙950˙035 €
 Programma FP7-NMP
Specific Programme "Cooperation": Nanosciences, Nanotechnologies, Materials and new Production Technologies
 Code Call FP7-NMP-2007-SME-1
 Funding Scheme CP-TP
 Anno di inizio 2008
 Periodo (anno-mese-giorno) 2008-09-01   -   2012-08-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    AHAVA DEAD SEA LABORATORIES LTD

 Organization address address: Hatsoref street 5
city: HOLON
postcode: 58856

contact info
Titolo: Mr.
Nome: Ofer
Cognome: Achdut
Email: send email
Telefono: +972 3 557 1119
Fax: +972 3 5581424

IL (HOLON) coordinator 0.00
2    A. BERENTS GMBH & CO KG

 Organization address address: HENLEINSTRASSE 19-21
city: STUHR
postcode: 28816

contact info
Titolo: Mr.
Nome: Florian
Cognome: Simpson
Email: send email
Telefono: +49 421 87111 24
Fax: +49 421 87111

DE (STUHR) participant 0.00
3    AFCON HOLDINGS LTD

 Organization address address: HATAVOR LANE INDUSTRIAL ZONE SEGULA 4
city: PETAH TIKVA
postcode: 49691

contact info
Titolo: Mr.
Nome: Avi
Cognome: Yofer
Email: send email
Telefono: +972 3 9392318
Fax: +972 3 9229661

IL (PETAH TIKVA) participant 0.00
4    DERMATEST GESELLSCHAFT FUR ALLERGOLOGISCHE FORSCHUNG U VERTRIEB VON KORPERPFLEGEMITTELN MBH

 Organization address address: ENGELSTRASSE 37
city: MUNSTER
postcode: 48143

contact info
Titolo: Dr.
Nome: Gerrit
Cognome: Schlippe
Email: send email
Telefono: +49 251 4882254
Fax: +49 251 4902727

DE (MUNSTER) participant 0.00
5    FUNDACION GAIKER

 Organization address address: Parque Tecnologico de Zamudio, Edificio 202
city: ZAMUDIO
postcode: 48170

contact info
Titolo: Mr.
Nome: Oscar
Cognome: Salas
Email: send email
Telefono: +34 946 00 23 23
Fax: +34 946 00 23 24

ES (ZAMUDIO) participant 0.00
6    INI-NOVATION UK LIMITED

 Organization address address: KINGS AVENUE WINCHMORE HILL 1
city: LONDON
postcode: N21 3NA

contact info
Titolo: Mr.
Nome: Constantinos
Cognome: Thiopoulos
Email: send email
Telefono: -3421498
Fax: -7066577

UK (LONDON) participant 0.00
7    MAPI-NAXIS SAS

 Organization address address: rue de la Villette 27
city: LYON
postcode: 69003

contact info
Titolo: Mr.
Nome: Jean-Louis
Cognome: Menard
Email: send email
Telefono: +33 4 72136585
Fax: +33 4 72136590

FR (LYON) participant 0.00
8    OSM-DAN LTD.

 Organization address address: Pekeris Street 4
city: REHOVOT
postcode: 76702

contact info
Titolo: Dr.
Nome: Pnina
Cognome: Dan
Email: send email
Telefono: +972 8 9460012
Fax: +972 8 9361486

IL (REHOVOT) participant 0.00
9    SISTEMAS GENOMICOS SL

 Organization address address: RONDA G MARCONI - PARQUE TECNOLOGICO DE VALENCIA 6
city: PATERNA
postcode: 46980

contact info
Titolo: Mr.
Nome: David
Cognome: Garcia Alfonso
Email: send email
Telefono: +34 902 364 669
Fax: +34 902 364 670

ES (PATERNA) participant 0.00
10    STIFTELSEN SINTEF

 Organization address address: Strindveien 4
city: TRONDHEIM
postcode: 7465

contact info
Titolo: Ms.
Nome: Marit
Cognome: Johnsen
Email: send email
Telefono: +47 93059140
Fax: +47 73597043

NO (TRONDHEIM) participant 0.00
11    STRATICELL SCREENING TECHNOLOGIES

 Organization address address: RUE JEAN SONET 10 PARC SCIENTIFIQUE CREALYS CRI ANDROMEDE
city: GEMBLOUX LES ISNES
postcode: 5032

contact info
Titolo: Dr.
Nome: Michel
Cognome: Salmon
Email: send email
Telefono: 3281728580
Fax: 3281728589

BE (GEMBLOUX LES ISNES) participant 0.00
12    THE HEBREW UNIVERSITY OF JERUSALEM.

 Organization address address: GIVAT RAM CAMPUS
city: JERUSALEM
postcode: 91904

contact info
Titolo: Dr.
Nome: Eran
Cognome: Vardi
Email: send email
Telefono: +972 2 6586668
Fax: +972 2 6513205

IL (JERUSALEM) participant 0.00
13    TROYKA MAKINA GIDA INSAAT MUHENDISLIK ENERJI CEVRE BILISIM ARASTIRMA GELISTIRME DANISMANLIK SANAYI VE PAZARLAMA LIMITED SIRKETI

 Organization address address: ODTU TEKNOKENT IKIZLER BINASI
city: ANKARA
postcode: 6531

contact info
Titolo: Prof.
Nome: Nuri
Cognome: Akkas
Email: send email
Telefono: 905327000000
Fax: 903122000000

TR (ANKARA) participant 0.00
14    UNIVERSITA DI PISA

 Organization address address: Lungarno Pacinotti 43/44
city: PISA
postcode: 56126

contact info
Titolo: Dr.
Nome: Immacolata
Cognome: Viva
Email: send email
Telefono: +39 050 2219391
Fax: +39 050 2219260

IT (PISA) participant 0.00
15    WINZSOFT (ISRAEL) LTD

 Organization address address: Beit Hillel 3
city: TEL AVIV-JAFFO
postcode: 67017

contact info
Titolo: Dr.
Nome: Abraham
Cognome: Meidan
Email: send email
Telefono: +972 3 5631991
Fax: +972 3 5611945

IL (TEL AVIV-JAFFO) participant 0.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

extensive    contact    combined    supporting    invasive    matching    sampling    palmitate    psoriasis    bio    dead    patterns    dermatologists    minerals    refined    customers    corresponding    drug    informatics    personalized    clinical    biomarker    ageing    generation    create    life    uv    personalised    health    skin    specifically    photo    accurate    markers    mining    radiation    dermatitis    statistical    selected    treat    therapy    team    few    sea    profiles    conventional    decision    pharmaceutical    retinyl    protocols    biomarkers    nano    drugs    software    salts    technologies    biological    sub    studied    disorders    computer    skintreat    expectancy    treatments    data    diagnosis    diseases   

 Obiettivo del progetto (Objective)

'Economical and health interests of skin problems are fast growing issues in Europe, following the remarkable extension in life expectancy in western countries, together with the increased awareness of UV radiation risks. Personalized health care approach has been discussed over the past few years and had been accompanied by developing innovative technologies capable of identifying specific biomarkers, supporting a personalized diagnosis and treatments, especially concerning bio-compatibility of drugs. Skin Treat intends to develop and validate nano-chemical and bio- technologies to achieve an accurate matching of drugs, and drug delivery vehicles, to skin diseases and sub pathogenic skin conditions in their individual context. The project will design novel generation of pharmaceutical products, as well as consumer personalized service, in order to fit customers’ tailored needs with a support of strategic consortium based on partnership among SMEs and research organizations. The development of personalized skin therapy protocols requires achieving an accurate diagnostics of skin condition and an extensive analysis of biological markers. Non invasive methods as well as minimal invasive skin sampling, will support the establishment of a range of biological profiles corresponding to skin diseases and skin sub pathologic conditions. Statistical processing of these data will allow defining biomarkers patterns specifically associated with given clinical conditions. A bio-informatics data mining protocol will be elaborated, together with multifunctional biomarker analysis software, to build a refined, personalized diagnosis method. Finally, the computer data analysis will yield a decision support system (DSS) to assist dermatologists, chemist and clients for prescription of personalized treatment. Skin Treat concept will be evaluated by a wet pilot study of the whole ervice chain on a few, selected skin disorders like psoriasis, contact dermatitis, and UV skin photo-aging damages.'

Introduzione (Teaser)

Healing salts and nanotechnology combine to create skin creams that could counter skin ageing and relieve a variety of skin ailments.

Descrizione progetto (Article)

Skin diseases are adversely affecting Europeans more than ever before, not least because of prolonged life expectancy and increased exposure to UV radiation from sunlight. A new, more personalised concept in healthcare and drug administration is now possible thanks to technological advances and biomedicine.

The EU-funded project 'Novel approaches for the development of customised skin treatments and services' (SkinTreat) is developing biotechnology and nanochemical drugs tailor-made to match patients' needs, and delivering these drugs more efficiently. It is focusing on combining conventional drugs and Dead Sea salts with new technologies and disciplines.

The project team is designing a new generation of personalised pharmaceutical products matching customers with their ideal treatments. The development of personalised skin therapy protocols requires accurate diagnosis of skin conditions plus an extensive analysis of biological markers.

Non-invasive methods and minimally invasive skin sampling have identified a range of biological profiles corresponding to skin diseases and subclinical skin conditions. Statistical data processing has enabled researchers to observe biomarker patterns specifically associated with various clinical conditions.

A bio-informatics data-mining approach combined with biomarker analysis software is also supporting a refined, personalised diagnosis method. In addition, computer data analysis is used to create a decision support system to help dermatologists and pharmacists prescribe personalised treatments.

The SkinTreat approach is being evaluated for selected skin disorders such as psoriasis, contact dermatitis, and UV skin photo-ageing, and a feasibility study is being conducted.

Retinyl palmitate, a preformed version of vitamin A, is being studied as a conventional dermal drug, to be combined with more unconventional substances like Dead Sea minerals. All drug delivery systems will contain Dead Sea minerals. The team studied several capsule and nano-emulsion for application and delivery, narrowing them down to seven water-based and five oil-based systems. Both nano-emulsions and nano-dispersions containing Dead Sea minerals and retinyl palmitate were successfully prepared and deemed safe after testing.

Altri progetti dello stesso programma (FP7-NMP)

EDEFU (2010)

New Designs of Ecological Furnaces

Read More  

CARBOPREC (2014)

Renewable source nanostructured precursors for carbon fibers

Read More  

NANODIARA (2010)

Development of novel nanotechnology based diagnostic systems for Rheumatoid Arthritis and Osteoarthritis

Read More